WAT vs ZVRA · P/E 32, rev $3.17B vs P/E 6.3, rev $75.9M
Waters Corporation (WAT) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
WAT currently screens at market cap $20.84B and trailing P/E 31.8. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the WAT and ZVRA stock pages for the full models.
Not investment advice.